Show simple item record

dc.contributor.authorScarffe, J Howard
dc.date.accessioned2010-08-02T10:08:23Z
dc.date.available2010-08-02T10:08:23Z
dc.date.issued1991
dc.identifier.citationEmerging clinical uses for GM-CSF. 1991, 27 (11):1493-504 Eur. J. Canceren
dc.identifier.issn0959-8049
dc.identifier.pmid1835868
dc.identifier.urihttp://hdl.handle.net/10541/108798
dc.language.isoenen
dc.subjectCanceren
dc.subject.meshAcquired Immunodeficiency Syndrome
dc.subject.meshBone Marrow Transplantation
dc.subject.meshDose-Response Relationship, Drug
dc.subject.meshGranulocyte-Macrophage Colony-Stimulating Factor
dc.subject.meshHumans
dc.subject.meshLeukocyte Count
dc.subject.meshMyelodysplastic Syndromes
dc.subject.meshNeoplasms
dc.subject.meshNeutropenia
dc.titleEmerging clinical uses for GM-CSF.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, Christie Hospital, Withington, Manchester, U.K.en
dc.identifier.journalEuropean Journal of Canceren


This item appears in the following Collection(s)

Show simple item record